Publication Type:

Journal Article


Indian Journal of Dermatology, Venereology and Leprology, Volume 79, Number 5, p.613-625 (2013)



17alpha estradiol, acrylic acid, antiandrogen, botulinum toxin, caffeine, clinical feature, conference paper, cyproterone acetate, dexpanthenol, dimeticone, drug efficacy, drug mechanism, dutasteride, erectile dysfunction, evidence based medicine, eye swelling, finasteride, gynecomastia, hair transplantation, hormonal therapy, human, hypertrichosis, libido disorder, low level laser therapy, male type alopecia, minoxidil, molecular pathology, nicotinamide, pathogenesis, pathophysiology, patient counseling, phototherapy, postoperative hemorrhage, postoperative pain, retinoic acid, scar formation, skin allergy, skin biopsy, skin irritation, surgical infection, topical treatment


Androgenetic alopecia (AGA) is one of the commonest reasons for dermatological consultation. Over the last few years our understanding of the pathophysiology of AGA has improved and this has paved way for better diagnostic and therapeutic options. Recent research has dwelled on the role of stem cells in the pathophysiology of AGA and has also identified newer genetic basis for the condition. Dermoscopy/trichoscopy has emerged as a useful diagnostic tool for AGA. While the major treatment options continue to be topical minoxidil, systemic Finasteride and hair transplantations, newer modalities are under investigation. Specific diagnostic and treatment recommendations have also been developed on evidence based principles. This article reviews the recent concepts in relation to AGA. With regards to the pathophysiology we have tried to stress on recent knowledge of the molecular and genetic basis of AGA. We have emphasized on an evidence based approach for treatment and diagnosis.


cited By (since 1996)0

Cite this Research Publication

Fad Kaliyadan, Nambiar, Ab, and Vijayaraghavan, Sc, “Androgenetic alopecia: An update”, Indian Journal of Dermatology, Venereology and Leprology, vol. 79, pp. 613-625, 2013.